Medicare's coverage of end-of-life chemotherapy led a patient to pursue aggressive treatment for a roughly 20% chance of benefit, even though her prognosis was an 80% likelihood of dying within two years, because the cost was not a financial burden to her or her children.

causalpending

Speaker

Steven Lipstein

Evidence Quote

“there's an 80% likelihood that you're in your last two years of life would she have said well I want the treatment to see if I'm in the 20%”

Source

Steven Lipstein on Hospitals 12/08/2008— EconTalk
Created: 11/1/2026, 3:58:19 PM

Your notes

Loading notes...